Skip to main content

Table 3 Hodgkin's lymphoma treatment response analysis.

From: An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients

Clinical data N Complete
response (%)
N Refractory/
relapsed (%)
p value
Gender      
   Male 13 72.2 5 27.8 0.286
   Female 17 85.0 3 15.0  
HL Subtype      
   Nodular sclerosis 21 84.0 4 16.0 0.220
   Mixed cellularity 5 55.6 4 44.4  
   Lymphocyte predominant 2 100.0 0 0  
   Unclassified 2 100.0 0 0  
Ann Arbor staging      
   Early (I or II) 15 88.2 2 11.8 0.195
   Advanced (III or IV) 15 71.4 6 28.6  
EBV status      
   Negative 21 100.0 0 0 < 0.001
   Positive 9 52.9 8 47.1  
CTA positivity      
   0 CT 24 80.0 6 20.0 0.954
   > or = 1 6 75.0 2 25.0  
MAGE-A      
   negative 24 77.4 7 22.6 0.538
   positive 6 85.7 1 14.3  
CT7      
   negative 27 81.8 6 18.2 0.279
   positive 3 60 2 40